#JPM22 goes vir­tu­al, cav­ing to pres­sure af­ter a wave of big drug­mak­ers pull out due to Omi­cron fears

Well, see you in Jan­u­ary 2023.

In a sur­prise about-face, #JPM22 will now be ful­ly vir­tu­al af­ter or­ga­niz­ers of the pop­u­lar biotech con­fer­ence de­cid­ed to pull the plug on a live event in San Fran­cis­co giv­en fears over the Omi­cron vari­ant and a grow­ing cho­rus of drug­mak­ers opt­ing out.

The move is no big sur­prise af­ter re­ports swirled about some of the in­dus­try’s biggest play­ers nix­ing plans to at­tend live and pres­sur­ing the bank to re­con­sid­er the an­nu­al meet at the West­in St. Fran­cis. STAT re­port­ed Tues­day that Mod­er­na and Am­gen, among oth­er large drug­mak­ers, had al­ready pulled out.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN